Evidence Synthesis
Gland's gross margin accelerated to 59.16%, up from 21%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 17 Sept 2026, 00:43
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Gland's gross margin accelerated to 59.16%, up from 21%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 59.16 % | 21 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 21 % | 16.78 | ▲ |
| REVENUE_GROWTH_YOY | 19.6 % | 46.9 | ▼ |
| EPS_ACTUAL | 11.15 INR | 16.976 | ▼ |
| EPS_SURPRISE_PERCENT | -0.14 % | 0.18 | ▼ |
| PRICE_CHANGE_PERCENT | -2.38 % | — | - |
| DAILY_VOLUME | 7,48,735 shares | 7,45,564 | ▲ |
| CLOSE_PRICE | 2,826.6 INR | 2,895.5 | ▼ |
| NEWS_SENTIMENT_SCORE | 0.43 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 3 count | 7 | ▼ |
| TARGET_PRICE_PREMIUM | 1.04 % | — | - |